Release Date: 12/06/18 11:25 Summary: Consent of the General Shareholders Meeting of Bioton S.A. Price Sensitive: Yes Download Document 148.7KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%